ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Septerna Inc

Septerna Inc (SEPN)

12.96
1.41
(12.21%)
Closed 16 February 8:00AM
13.15
0.19
(1.47%)
After Hours: 11:33AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
13.15
Bid
12.70
Offer
22.36
Volume
199,071
11.405 Day's Range 13.19
10.34 52 Week Range 28.99
Market Cap
Previous Close
11.55
Open
12.00
Last Trade Time
Financial Volume
US$ 2,438,089
VWAP
12.2473
Average Volume (3m)
322,528
Shares Outstanding
44,402,742
Dividend Yield
-
PE Ratio
137.94
Earnings Per Share (EPS)
0.09
Revenue
151k
Net Profit
4.18M

About Septerna Inc

Septerna is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by its proprietary Native Complex Platform. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the dis... Septerna is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by its proprietary Native Complex Platform. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Our lead product candidate, SEP-786, is a clinical-stage, oral small molecule agonist targeting PTH1R for the treatment of hypoparathyroidism. We have successfully completed Investigational New Drug (IND)-enabling studies and have initiated a Phase 1 clinical trial to assess preliminary safety, tolerability, PK, and PD of SEP-786. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Septerna Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SEPN. The last closing price for Septerna was US$11.55. Over the last year, Septerna shares have traded in a share price range of US$ 10.34 to US$ 28.99.

Septerna currently has 44,402,742 shares in issue. The market capitalisation of Septerna is US$512.85 million. Septerna has a price to earnings ratio (PE ratio) of 137.94.

SEPN Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.095-7.6869076869114.24514.2510.3432367712.06069705CS
4-3.89-22.828638497717.0420.4810.3426280414.95214293CS
12-8.82-40.145653163421.9728.9910.3432252821.04682512CS
26-10.35-44.042553191523.528.9910.3430882921.36235608CS
52-10.35-44.042553191523.528.9910.3430882921.36235608CS
156-10.35-44.042553191523.528.9910.3430882921.36235608CS
260-10.35-44.042553191523.528.9910.3430882921.36235608CS

SEPN - Frequently Asked Questions (FAQ)

What is the current Septerna share price?
The current share price of Septerna is US$ 13.15
How many Septerna shares are in issue?
Septerna has 44,402,742 shares in issue
What is the market cap of Septerna?
The market capitalisation of Septerna is USD 512.85M
What is the 1 year trading range for Septerna share price?
Septerna has traded in the range of US$ 10.34 to US$ 28.99 during the past year
What is the PE ratio of Septerna?
The price to earnings ratio of Septerna is 137.94
What is the cash to sales ratio of Septerna?
The cash to sales ratio of Septerna is 3.82k
What is the reporting currency for Septerna?
Septerna reports financial results in USD
What is the latest annual turnover for Septerna?
The latest annual turnover of Septerna is USD 151k
What is the latest annual profit for Septerna?
The latest annual profit of Septerna is USD 4.18M
What is the registered address of Septerna?
The registered address for Septerna is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
Which industry sector does Septerna operate in?
Septerna operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
JTAIJet AI Inc
US$ 6.02
(133.33%)
104.48M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
254.39M
WRDWeRide Inc
US$ 31.4877
(83.39%)
21.07M
INLFINLIF Limited
US$ 16.27
(80.58%)
7.68M
MBRXMoleculin Biotech Inc
US$ 2.1201
(66.94%)
136.66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3.08
(-56.31%)
425.19k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
US$ 19.0001
(-49.58%)
1.01M
NEXNNexxen International Ltd
US$ 10.30
(-49.16%)
160.99k
BSLKBolt Projects Holdings Inc
US$ 0.6626
(-46.13%)
13.07M
CNSPCNS Pharmaceuticals Inc
US$ 0.1415
(31.26%)
489.28M
MGOLMGO Global Inc
US$ 0.7176
(-15.08%)
417.31M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
254.39M
INTCIntel Corporation
US$ 23.60
(-2.20%)
230.26M
NVDANVIDIA Corporation
US$ 138.85
(2.63%)
194.99M

Discussion

View Full Feed
JSmith5 JSmith5 5 minutes ago
There has been such silence I’m not sure he is taking the position.

If he doesn't we will all be taking the position.

Nats
FNMA
rocioyogi rocioyogi 6 minutes ago
No, actually what would happen which I would love because we would not have to cash in and pay taxes until we’re ready if we got stock for stock if hypothetically their stock was worth $30 and Nas agreed on five dollars a share is our value than we would get Six shares of their $30 stock which would
ELTP
JamesF1 JamesF1 6 minutes ago
My GUESS is the next press release says “Elite has hired (one of the firms Nasrat mentioned) to explore opportunities”.
ELTP
The ELTP King The ELTP King 8 minutes ago
Nasrat has said these three things on EVERY conference call going back 18 months.

There was NOTHING special about the conference call a few days ago.

These words were M&a, move to Nasdaq, ,amazing quota, lol
ELTP
Mr Gyamfi Mr Gyamfi 10 minutes ago
Looking for investors who is interested in investing in Indian almonds leaves and it fruits..very highly recommended in Europe and America (egyamfi18@gmail.com) contact me
CNSP
elks elks 11 minutes ago
Added more dip. Just matter time rip over buck.
TIVC
HGilS HGilS 12 minutes ago
Hi sharkey

We, the older one on this board are having our prayers answered.

Thursday evening after th filing, I posted to Nasdaq2020 in private some keywords I would like to hear about n the teleconference the next day.

These words were M&a, move to Nas
ELTP
eagle8 eagle8 20 minutes ago
autologous assassin 🇺🇸 🇺🇦 🇮🇱
@flaskworks
You're absolutely right. That argument is a slam dunk because it highlights a major legal error in Judge Stein’s reasoning—he improperly relied on extrinsic evidence rather than limiting his analys
NWBO
ksquared ksquared 25 minutes ago
HAPPY BIRTHDAY, Larrykins ! ! !
Good to see you up and at 'em on your special day.
Here's to your health and longevity. Celebrate!
https://investorshub.advfn.com/uimage/uploads/2025/2/16/cdzvrdownload.jpg
elks elks 30 minutes ago
Fill my boat ill stay the course
GVSI
KIPK KIPK 42 minutes ago
JONDOEUK,
This thing is more air than oxygen .. Just like your NVCR...

You know who is coming?? 👀
NVCR
mrfence mrfence 43 minutes ago
You've put yourself on ignore, lol!
FNMA
KIPK KIPK 45 minutes ago
Try harder jondoeuk. If as you colluded......

>>>>>>>Finally, NWBO is a shitco scam >>>>

Why are you so afraid of NWBO....

I AM SURE YOU KNOW WHY!!
NWBO
SilkRoad SilkRoad 48 minutes ago
Drop in and go using existing infrastructure. That was the drumbeat we heard many moons ago. But every step of the way they have to seemingly build a new facility, bring in and/or modify equipment, add a lab, add testing, get a license, open an office, and bring in outside experts. I think you ar
KBLB
Peter J Peter J 50 minutes ago
no matter what desperate attempts they try in order to attract buyers there is something called common sense that most investors use to stay away from a disaster like ERHC.
Come on badog, get real please: talking solely about your and ssc's motives for posting here can hardly qualify as tryin
ERHE
chereb19 chereb19 57 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/2/16/kprkvScreenshot_2025-02-16-11-06-05-307_com.twitter.android-edit.jpg
RDGL
Peter J Peter J 1 hour ago
Badog, read the 6th post, how relevant, again!

https://www.lse.co.uk/profiles/supercooper/
I also don't post on boards where I have no holdings. Why on earth are you posting on the Tlw board if you have no interest Long or Short. Trying to make yourself feel good by denigrating
ERHE
sharkey1 sharkey1 1 hour ago
Hypothetical press release:

Tuesday AM.
Elite is in talks with XYZ company, no name yet, and they are huge with billions
in the market cap, and there stock is worth 30 bucks a share.
And theres a leak as to who it is.
Elites stock will shoot up fast to me
XYZ
baltimorebullet baltimorebullet 1 hour ago
One wildcard no one is mentioning is other indebted developed countries may follow the U.S. and begin to reduce their government employee headcounts.
That could slow down the EMA among many other things.
AVXL
sharkey1 sharkey1 1 hour ago
Can’t sleep, waiting for the M and A news that could come Tuesday morning.
It’s a 3 day weekend, they could be working on anything. Instead of merger Monday
could be merger Tuesday.
ELTP

Your Recent History

Delayed Upgrade Clock